Assuming success is required, the following results were found.

  • A Chinese drug maker scores a big clinical trial win with a novel diabetes therapy - STAT

    Two years ago, Hua Medicine turned to the public markets to help finance its ambitious diabetes program. “Our future success depends substantially on the success in China of our only clinical drug candidate, dorzagliatin,” the Shanghai-based pharma...

    https://mschristian.org/index.php/a-chinese-drug-maker-scores-a-big-clinical-trial-win-with-a-novel-diabetes-therapy-stat
  • Read more about efforts to understand tissue damage in MS

    future damage.Developing high-powered imaging as a window to seeing how MS causes damage and as a tool for tracking the success of treatments.Past Success The MS Lesion Project was a major collaboration of investigators worldwide who sought to...

    https://mschristian.org/index.php/blog/read-more-about-efforts-to-understand-tissue-damage-in-ms
  • Managing Hep C; A New Migraine Therapy: It's PodMed Double T!

    undergo routine myotomy or to undergo POEM. They followed these individuals for 2 years. What they determined was there was success rate in 83% of those that had the POEM and 82% success rate in those that had the routine myotomy. Serious adverse...

    https://mschristian.org/index.php/articles/2-uncategorised/9498-managing-hep-c-a-new-migraine-therapy-it-s-podmed-double-t
  • Managing Hep C; A New Migraine Therapy: It's PodMed Double T!

    undergo routine myotomy or to undergo POEM. They followed these individuals for 2 years. What they determined was there was success rate in 83% of thosethat had the POEM and 82% success rate in those that had the routine myotomy. Serious adverse effects...

    https://mschristian.org/index.php/blog/managing-hep-c-a-new-migraine-therapy-it-s-podmed-double-t
  • Consumer Group: Harm Reduction Is a Human Right

    risks from smoking. What’s more, regulators must recognize that having a wide choice of products and flavors is key to the success of safer nicotine products in enabling people to stop smoking, according to the manifesto. Regulation must consider the...

    https://mschristian.org/index.php/consumer-group-harm-reduction-is-a-human-right
  • Wireless System Helps Tetraplegic Man 'Walk'

    involving both arms with up to 8 degrees of freedom simultaneously. With a virtual avatar at home, he achieved 64% success; with an exoskeleton in the laboratory, he achieved 70.9% success. The decoders could be used for up to 7 weeks without...

    https://mschristian.org/index.php/articles/2-uncategorised/8829-wireless-system-helps-tetraplegic-man-walk
  • Better Buy: GlaxoSmithKline vs. Bristol Myers Squibb - Motley Fool

    on consumer health and the other on pharmaceuticals and vaccines. But over the long term, GSK could be positioned for success. The company claims several relatively new drugs on the market that should drive growth for years to come. Sales for...

    https://mschristian.org/index.php/blog/better-buy-glaxosmithkline-vs-bristol-myers-squibb-motley-fool
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    1. Sanofi Sanofi (NASDAQ:SNY) has been making headlines for its work on coronavirus treatment and prevention. While any success there would be a plus, my attention is on products with more potential for long-term growth. Sanofi must find ways to...

    https://mschristian.org/index.php/blog/my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool
  • 3-8 Local business briefs - Norman Transcript

    sessions with prayer and offering a brief devotional on the last day of each legislative week. Woody achieves Circle of Success recognition Mark E. Woody, CFP, CLU, ChFC, APMA, CASL, CKA, a private wealth advisor with Kindred Wealth, a private wealth...

    https://mschristian.org/index.php/blog/3-8-local-business-briefs-norman-transcript
  • Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone - P&T Community

    at Nuvaira. "His experience guiding start-up medical device companies through the critical clinical development phase with successful transition to commercial growth and public market offerings will be critical to Nuvaira's continued progress and...

    https://mschristian.org/index.php/blog/nuvaira-announces-chief-financial-officer-and-pivotal-study-milestone-p-t-community
  • Trending News Today: FDA Accepts NDA for Topical Rosacea Treatment - Pharmacy Times

    of statistically significant improvements in inflammatory lesion count and Investigator Global Assessment treatment success. The FDA has set June 2, 2020, as the Prescription Drug User Fee Act action date, the article reported. A new study found that...

    https://mschristian.org/index.php/blog/trending-news-today-fda-accepts-nda-for-topical-rosacea-treatment-pharmacy-times
  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    create the biologic basis for effective drug-based therapy, medical understanding and engagement provide the keys to success with a digitized cognitive behavior therapy program. This collaboration will marry Sanofi’s patient focus and medical and...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • icometrix selected as one of the 150 most innovative digital health startups worldwide by CB Insights - PRNewswire

    privilege to use CB Insights' data to identify and shine a light on these companies, and we look forward to tracking their success in 2019 and beyond." "We are honored to receive this recognition by CB Insights," said Prof. Wim Van Hecke, CEO of...

    https://mschristian.org/index.php/blog/icometrix-selected-as-one-of-the-150-most-innovative-digital-health-startups-worldwide-by-cb-insights-prnewswire
  • Coronavirus Outbreak: Daily Updates

    vaccines will take place this summer. Getty Images A formerly healthy woman in her 20s who developed COVID-19 underwent a successful lung transplant, according to physicians at Northwestern Medical Center. The woman, whose name hasn’tbeen released, had...

    https://mschristian.org/index.php/coronavirus-outbreak-daily-updates
  • Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone - P&T Community

    at Nuvaira. "His experience guiding start-up medical device companies through the critical clinical development phase with successful transition to commercial growth and public market offerings will be critical to Nuvaira's continued progress and...

    https://mschristian.org/index.php/articles/2-uncategorised/9958-nuvaira-announces-chief-financial-officer-and-pivotal-study-milestone-p-t-community
  • Cortica Announces Leadership Appointments And Strategic Investment By Ajax Health And Questa Capital - P&T Community

    one community at a time. "We are thrilled to have attracted a team of leaders and investor partners with a proven record of success and an unwavering commitment to helping children with neurodevelopmental differences and their families," said Neil...

    https://mschristian.org/index.php/articles/2-uncategorised/9752-cortica-announces-leadership-appointments-and-strategic-investment-by-ajax-health-and-questa-capital-p-t-community
  • SLU researcher honored for finding better pain treatments

    Salvemini'selection comes just a few months after five SLU faculty members were named NAI Senior Members for their strong success in patents and commercialization. In her election as a Fellow of the NAI, Salvemini joins SLU colleague Richard Bucholz,...

    https://mschristian.org/index.php/articles/2-uncategorised/9644-slu-researcher-honored-for-finding-better-pain-treatments
  • TG Therapeutics Announces $50.0 Million Registered Direct Public Offering of Common Stock to a Single Institutional Investor - GlobeNewswire

    to manage our cash burn in line with our expectations to meet projected cash estimates and projected cash runway; the success and timing of our clinical trials and preclinical studies for our product candidates, including site initiation, internal...

    https://mschristian.org/index.php/articles/2-uncategorised/9643-tg-therapeutics-announces-50-0-million-registered-direct-public-offering-of-common-stock-to-a-single-institutional-investor-globenewswire
  • Multiple sclerosis group holds festive lunch at SportsAble - Windsor Express

    with MS and their relatives to get out and about and meet others who are in similar circumstances. “The lunch was a great success, enjoyed by all and ended with a raffle that raised £357.” The group invites anyone affected by multiple sclerosis to join...

    https://mschristian.org/index.php/articles/2-uncategorised/9551-multiple-sclerosis-group-holds-festive-lunch-at-sportsable-windsor-express
  • Trending News Today: FDA Accepts NDA for Topical Rosacea Treatment - Pharmacy Times

    of statistically significant improvements in inflammatory lesion count and Investigator Global Assessment treatment success. The FDA has set June 2, 2020, as the Prescription Drug User Fee Act action date, the article reported. A new study found that...

    https://mschristian.org/index.php/articles/2-uncategorised/8954-trending-news-today-fda-accepts-nda-for-topical-rosacea-treatment-pharmacy-times

Results 1 - 20 of 41